Neoplasms clinical trials
The registry lists 10,826 studies for Neoplasms across more than 10 countries. 2,322 are recruiting or about to start. 5,799 of them are mainly about Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-16. Counting its 377 narrower conditions too, such as Breast Neoplasms: 113,224 studies, 27,682 open.
ClinicalTrials.gov finds 124,774 studies for Neoplasms. How that becomes 10,824 here
This page counts the studies the registry files under Neoplasms, and those it files under no condition that list Neoplasmsthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 15, 2026. How condition pages count
- 124,774Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
- −100,285Filed under a narrower condition, counted on its own pageBreast Neoplasms 12,831 · Carcinoma, Non-Small-Cell Lung 6,351 · Prostatic Neoplasms 5,600 · Colorectal Neoplasms 4,993 · Multiple Myeloma 3,387 · Leukemia, Myeloid, Acute 3,124 · 339 more
- −7,143List Neoplasms as a condition, but the registry did not file them under itMost often written as “Advanced Solid Tumors” (534), “Solid Tumor” (495), and “Unspecified Adult Solid Tumor, Protocol Specific” (461). The registry filed 5,401 of them under no condition at all, and the others under other conditions only, most often Cancer Pain (131) and Myeloproliferative Disorders (95).
- −6,522Match it another way4,306 name it in the title, 457 in a keyword, and 1,759 by a synonym or other text the search reads.
- 10,824The count on this page
Status
Who runs them
National Cancer Institute (NCI) (265) · M.D. Anderson Cancer Center (164) · GlaxoSmithKline (136) · AbbVie (129) · AstraZeneca (106) · Novartis Pharmaceuticals (100) · Memorial Sloan Kettering Cancer Center (87) · Pfizer (80)
What is being tested here
Drugs under test in Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Pembrolizumab | 14 | 4 | 40 |
| Bevacizumab | 9 | 7 | 69 |
| Atezolizumab | 9 | 9 | 30 |
| Trastuzumab | 8 | 4 | 16 |
| Dexamethasone | 7 | 9 | 34 |
| Nivolumab | 7 | 2 | 27 |
| Olaparib | 7 | 2 | 24 |
| Cobimetinib | 6 | 2 | 13 |
| Pertuzumab | 6 | 3 | 10 |
| Gallium-68 | 6 | 0 | 8 |
Drug classes tested here Immune checkpoint inhibitors 69 open · Tyrosine kinase inhibitors (TKIs) 41 open · Antimetabolites 20 open · Angiogenesis inhibitors 15 open · PARP inhibitors 15 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Nov 2026PREVENT HPV -Related Cancers Trial · Phase 3 · University of Utah
- Nov 2026Pharmacogenomics ANDA SNP Clinical Study - Etoposide and Single Nucleotide Polymorphisms · Phase 3 · Han Xu, M.D., Ph.D., FAPCR, Medical Director,, IRB Chair
- Nov 2026Pharmacogenomics IND Commercial SNP Clinical Study - Abiraterone and Single Nucleotide Polymorphisms · Phase 3 · Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair
- Nov 2026A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer · Phase 3 · Tesaro, Inc.
- Nov 2026A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A) · Phase 3 · Hoffmann-La Roche
- Dec 2026Primary Thromboprophylaxis in Patients With Malignancy and Central Venous Catheters · Phase 3 · Ottawa Hospital Research Institute
- Dec 2026Olanzapine in the Prevention and Treatment of Anorexia-Cachexia Syndrome in Patients Receiving Neoadjuvant/Preoperative Chemotherapy · Phase 3 · Blokhin's Russian Cancer Research Center
- Dec 2026Glutamine for the Prophylaxis of Vincristine-induced Neuropathy in Children and Adolescents With Cancer. · Phase 3 · Ain Shams University
- Dec 2026Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC) · Phase 3 · Qilu Pharmaceutical Co., Ltd.
- Dec 2026Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Durvalumab · Phase 3 · AstraZeneca
Who these studies take
Of the 1,718 Neoplasms studies recruiting now, 1,173 (68%) set no upper age limit and 333 (19%) stop at 75 or younger. 337 (20%) take children under 18. 90 (5%) are for women only and 35 (2%) for men only; 228 (13%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 263 (15%) | 257 (15%) |
| 18 | 1,497 (87%) | 1,465 (85%) |
| 30 | 1,468 (85%) | 1,419 (83%) |
| 40 | 1,464 (85%) | 1,415 (82%) |
| 50 | 1,468 (85%) | 1,425 (83%) |
| 65 | 1,485 (86%) | 1,439 (84%) |
| 75 | 1,444 (84%) | 1,404 (82%) |
| 85 | 1,286 (75%) | 1,252 (73%) |
Across all 10,826 studies, recruiting or not: 18% stop at 75 or younger and 12% at 65; 17% take children; 7% are for women only and 3% for men only; 11% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Neoplasms studies take
Of 904 phase 1 interventional studies under Neoplasms, half reached primary completion within 40 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 1 | 40 mo23–64 · 904 studies | 38 mo22–62 · 677 studies | 48 mo28–88 · 227 studies |
| Phase 1/2 | 60 mo39–89 · 297 studies | 61 mo41–88 · 195 studies | 59 mo33–111 · 102 studies |
| Phase 2 | 52 mo33–92 · 514 studies | 42 mo26–68 · 179 studies | 58 mo36–99 · 335 studies |
| Phase 2/3 | 44 mo28–90 · 47 studies | — | — |
| Phase 3 | 50 mo33–84 · 202 studies | 44 mo30–72 · 119 studies | 60 mo43–96 · 83 studies |
| Phase 4 | 38 mo21–64 · 88 studies | — | 33 mo21–56 · 64 studies |
| Interventional, no phase | 29 mo13–52 · 2,061 studies | 23 mo11–53 · 75 studies | 29 mo13–52 · 1,986 studies |
| Observational | 58 mo24–210 · 1,246 studies | 47 mo29–102 · 148 studies | 61 mo24–227 · 1,098 studies |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 18, 2026.
Started recruiting24
- A Single-Arm, Open-Label, Multicenter Phase I/II Clinical Study of GFH276 in Patients With RAS-Mutant Advanced Solid TumorsNov 16, 2026NCT07198321
- Study of a Propranolol (HEMANGIOL®) and Oral Metronomic Vinorelbine (NAVELBINE®) Combination for Children and Teenagers With Refractory/Relapsing Solid TumorsNov 12, 2026NCT02897986
- Feasibility Pilot of AYA-PARTNERNov 12, 2026NCT07829146
- Medically Tailored Meals to Improve Cancer OutcomesNov 12, 2026NCT07924241
- Effectiveness, Acceptability and Feasibility of a Communication and Care Coordinator (CCC) Model in Facilitating Serious Illness Communication (SIC) and Care in Patients With CancerNov 10, 2026NCT07733973
Show 19 moreShow fewer
- Improving Care Delivery for Patients With Mental Illness and Cancer Across a Cancer Center NetworkNov 9, 2026NCT07707362
- Analysis of Circulating Tumor Markers in Blood - ALCINA 5Nov 6, 2026NCT07060950
- Personalize My Treatment (PMT) RegistryNov 5, 2026NCT02355171
- COMUNICAR: Community-Led Family-Centered Communication for Cancer Survivorship CareNov 4, 2026NCT07606443
- Adjustment of Antibiotic Dosage in Pediatric Oncology Patients With Febrile Neutropenia and Augmented Renal ClearanceNov 3, 2026NCT06293677
- Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active SurveillanceNov 3, 2026NCT07574541
- Hope-Focused Motivational Interviewing in Cancer PatientsNov 2, 2026NCT07585838
- ABCSG R07 Rectal Cancer RegistryOct 30, 2026NCT07780305
- Keep Social Randomized Controlled Trial for Young Adults With CancerOct 30, 2026NCT07788339
- Improving Adherence to Chronic Disease Medication Regimens Among Patients With Recently Diagnosed CancerOct 30, 2026NCT07811258
- A Study of LP-118 In Combination With Ponatinib, Dexamethasone And Blinatumomab For Adults With Newly-Diagnosed, BCR::ABL1-Positive Acute Lymphoblastic Leukemia (ALL)Oct 29, 2026NCT07614022
- Biopsy-Resection Agreement of Peritoneal Histopathological Growth Patterns in Colorectal Peritoneal Metastases: A Prospective Observational Pilot StudyOct 26, 2026NCT07474025
- Smoking Cessation in Patients With CancerOct 26, 2026NCT07822464
- Neurocognitive Trajectories After BCMA CAR-TOct 23, 2026NCT07740317
- A Study in Patients Reporting Cannabis Use Followed With an Application-Based Cannabis JournalOct 22, 2026NCT07089225
- QoLIDia: Quality of Life in Cancer Patients With Diabetes During ImmunotherapyOct 22, 2026NCT07466212
- Smoking Relapse Prevention in Patients With CancerOct 21, 2026NCT07815912
- Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic SyndromesOct 20, 2026NCT07672769
- Real-world Evaluation of the Implementation of LC-OCT in Daily Clinical PracticeOct 19, 2026NCT07501780
Results posted7
- Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)Nov 12, 2026NCT05935748
- Oral Administration of STC-15 in Subjects With Advanced MalignanciesNov 9, 2026NCT05584111
- Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign DiseaseNov 5, 2026NCT01552434
- A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal CancerNov 4, 2026NCT03929666
- Intervening on Women's Health for Rural Young Cancer SurvivorsNov 3, 2026NCT06664034
Show 2 moreShow fewer
- SurvivorLink: Scalability of an Electronic Personal Health RecordOct 28, 2026NCT03543852
- Biology and Benefits of Music Play and Stories for Kids/Parents During ALL TreatmentOct 28, 2026NCT04400071
Stopped12
- Incorporating Biometric Data for Patients Receiving Concurrent Chemotherapy & RTWithdrawnNov 16, 2026NCT05937659
- A Study of Shengbai Oral Formula to Assess Safety and Alleviation of Adverse Effects in Cancer Patients Undergoing ChemotherapyTerminatedNov 12, 2026NCT06706752
- Cryptosporidium Infection and Human Colorectal CancerTerminatedNov 6, 2026NCT04332705
- Improving Cancer Prevention and Control Through Academic-local Public Health Department PartnershipsWithdrawnNov 6, 2026NCT06605196
- Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid TumorsTerminatedNov 5, 2026NCT05539157
Show 7 moreShow fewer
- CT-95 in Advanced Cancers Associated With Mesothelin ExpressionTerminatedNov 5, 2026NCT06756035
- xPedite: A Study to Expedite DIPG and DMG ResearchWithdrawnNov 2, 2026NCT06140719
- Distraction-Based Interventions During Implanted Venous Port Catheter Needle Entry: Virtual Reality ApplicationTerminatedOct 30, 2026NCT06551753
- Blue-Button Regional Trial ScreeningTerminatedOct 29, 2026NCT05885880
- From Screening to Support: A Multi-Method Analysis of HRSN Integration in Cancer CareTerminatedOct 29, 2026NCT07352579
- Study of Disulfiram to Reduce Myeloid Immunosuppression and Steroid Dependence in Resectable High Grade GliomaSuspendedOct 22, 2026NCT07719127
- Pyronaridine in Acute Myeloid Leukemia (AML)SuspendedOct 19, 2026NCT05291390
Newly registered48
- The Effect of Mindfulness-Based Cognitive Therapy on Nausea and Vomiting Management and Quality of Life in Oncology PatientsNov 16, 2026NCT07937722
- Cardiovascular Risk and Outcomes in Patients With Cancer: The TRACE-Cancer StudyNov 16, 2026NCT07939321
- ^68Ga-grazytracer PET for In Vivo Visualization of Immune Cell Effector FunctionsNov 13, 2026NCT07935174
- Effect of Therapeutic Storybook Series on Anxiety in Children Undergoing ChemotherapyNov 13, 2026NCT07936318
- Segmentectomy vs. Pulmonary Lobectomy in Resectable N1 NSCLC: The VESPER Study (VErification of Segmentectomy Versus Pulmonary Lobectomy in Resectable N1 Non-Small Cell Lung Cancer)Nov 12, 2026NCT07930858
Show 43 moreShow fewer
- Use of mHealth Application and Education to Increase Appropriateness of Thromboprophylaxis in Patients With CancerNov 12, 2026NCT07931053
- A Study of Urine Volatile Organic Compounds for Disease DetectionNov 12, 2026NCT07933042
- PharmaBag: A Sustainable Packaging System to Reduce Pharmaceutical Waste and Support a Net-Zero NHSNov 10, 2026NCT07927894
- A Study of LY4336619 in Adult Participants With Advanced Solid TumorsNov 10, 2026NCT07928258
- Social Media Perceptions Among Young Adults With Cancer - Online Experiment 1Nov 10, 2026NCT07928323
- Social Media Perceptions Among Young Adults With Cancer - Online Experiment 2Nov 10, 2026NCT07928349
- Medically Tailored Meals to Improve Cancer OutcomesNov 9, 2026NCT07924241
- Prognostic and Predictive Factors in Childhood Soft Tissue SarcomasNov 9, 2026NCT07924384
- Social Media Perceptions Among Young Adults With Cancer - Aim 1: InterviewsNov 9, 2026NCT07925879
- Symptom Burden by Level of Therapeutic Intensity in a Palliative Care UnitNov 9, 2026NCT07926841
- Phase 1/2 Study of DS010 in Advanced Cancer Patients With CachexiaNov 6, 2026NCT07921576
- Pilot Testing ACCOMPANI: A Nurse-Targeted Intervention to Promote Psychosocial Equity in Pediatric OncologyNov 6, 2026NCT07921589
- Automated Radiation Target Contouring and Treatment Planning Via RATA: A Multi-Center RCTNov 6, 2026NCT07922902
- A Study to Assess the Pharmacokinetics and Safety of Revumenib in Participants With Advanced Cancer and Hepatic or Renal ImpairmentNov 6, 2026NCT07923071
- Facial Expression Awareness Training to Understand and Recognize EmotionsNov 6, 2026NCT07923370
- Evaluation of Massage Therapy for Cancer Related Fatigue in Breast Cancer SurvivorsNov 5, 2026NCT07917845
- A Project Assessing the Safety and Feasibility of Using Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Ovarian Cancer During Surgical ProceduresNov 5, 2026NCT07919509
- Rowing-Based Exercise Intervention on Health and Quality of Life in Breast Cancer SurvivorsNov 5, 2026NCT07919730
- Performance of Multi-Cancer Detection Test in Asymptomatic Patients With Neoplastic LesionsNov 4, 2026NCT07915271
- Detection Technology of Peripheral Blood ctDNA Based on CRISPR/Cas and Gold NanoparticlesNov 4, 2026NCT07916636
- Prospective Multicenter Cohort Study of Clinical and Molecular Biomarkers in Colorectal CancerNov 3, 2026NCT07913802
- Alberta Cancer Exercise Dose in Colorectal CancerNov 3, 2026NCT07913906
- Intratumoral Chlorine Dioxide Injection in Advanced Solid TumorsNov 2, 2026NCT07911293
- Expanded Access Program to Provide STC-15 to Patients With Selected Advanced CancerOct 30, 2026NCT07906093
- Organoid Drug Sensitivity-Guided Therapy for Refractory TumorsOct 30, 2026NCT07906301
- Multicenter Study for External Validation of the TB-NET ScoreOct 29, 2026NCT07903532
- CANCER SCREENING PROGRAM ON UNCERTAINTY, ANTİCİPATORY ANXIETY, CANCER AWARENESS, AND E-HEALTH LITERACY IN A STROKE PATIENTSOct 29, 2026NCT07904247
- Implementation of a Pain Management Plan in Major Open Abdominal Surgeries.Oct 28, 2026NCT07901582
- AI-generated Treatment Recommendations in Precision OncologyOct 27, 2026NCT07897110
- Outcomes for IR and High Risk (HR) Non-muscle Invasive Bladder Cancer (NMIBC) and ctDNA-based Biomarkers for Response and Recurrence in Muscle Invasive Bladder Cancer (MIBC)Oct 26, 2026NCT07893509
- Twenty-five Years of Advanced RadioTherapy at San Raffaele HospitalOct 26, 2026NCT07894900
- A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) ABBV-706 in Combination With Alveltamig and Atezolizumab for Adults Participants With Extensive Stage-Small Cell Lung CancerOct 26, 2026NCT07895043
- A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) ABBV-706 in Combination With Tarlatamab and Atezolizumab in Adult Participants With Extensive Stage-Small Cell Lung CancerOct 26, 2026NCT07895056
- Clinical Outcomes of Stroke in MalIgnanCyOct 26, 2026NCT07895173
- Phase 2 Study of Oral Epetraborole in Adults With Polycythemia VeraOct 23, 2026NCT07891533
- Master Protocol for the Study of Rilogrotug for the Treatment of Weight Loss and Anorexia in Patients With Cancer Cachexia and mCRC or mNSCLCOct 22, 2026NCT07888075
- A Phase II Clinical Study Evaluating the Efficacy and Safety of SXRN Injection in Patients With Cancer CachexiaOct 22, 2026NCT07890324
- Dexmedetomidine for Refractory Pain in Palliative Cancer PatientsOct 21, 2026NCT07885475
- Symptom Monitoring and Management Intervention After CAR-TOct 21, 2026NCT07886190
- Pragmatic Interventions to Advance Cancer Survivor OutcomesOct 21, 2026NCT07886853
- Effect of ACTIVE-Care on Cancer-Related Fatigue, Hope, and Psychological Resilience in Adolescents With Acute Lymphoblastic LeukemiaOct 20, 2026NCT07882069
- Maternal and Fetal Outcomes in Pregnancy With MalignancyOct 20, 2026NCT07882329
- Safety and Diagnostic Efficacy of 177Lu-AF03 in Patients With Solid TumorsOct 19, 2026NCT07879547
Studies
Recruiting first, then most recently updated. Showing 50 of 10,826. Browse all 10,826 → or search them.
- A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D MutationRecruitingNCT06385925Phase 1/22 countries
- Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBMRecruitingNCT03213002Phase 1/21 country
- A Clinical Trial of MK-2010 With Sacituzumab Tirumotecan (Sac-TMT) in Participants With Solid Tumors (MK-2010)RecruitingNCT07785609Phase 23 countries
- Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family MembersEnrolling by invitationNCT000710451 country
- Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell CarcinomaRecruitingNCT066765271 country
- 000860: A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) MutationsRecruitingNCT05588141Phase 1/21 country
- Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent GlioblastomaRecruitingNCT07100730Phase 34 countries
- A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid TumorsRecruitingNCT07213609Phase 1/29 countries
- A Single-Arm, Open-Label, Multicenter Phase I/II Clinical Study of GFH276 in Patients With RAS-Mutant Advanced Solid TumorsRecruitingNCT07198321Phase 1/21 country
- Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active SurveillanceRecruitingNCT07574541Phase 21 country
- Prevention of Opioid-induced Constipation in Patients With Advanced CancerRecruitingNCT05216328Phase 41 country
- Cardiovascular Risk and Outcomes in Patients With Cancer: The TRACE-Cancer StudyNot yet recruitingNCT07939321
- Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump TherapyNot yet recruitingNCT07715903Phase 11 country
- Response to Influenza Vaccination in Pediatric Oncology PatientsRecruitingNCT053842881 country
- Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological CancersRecruitingNCT06906341Phase 28 countries
- SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer SurvivorsRecruitingNCT07161713Not applicable1 country
- Clinical Genetics Branch Eligibility Screening SurveyNot yet recruitingNCT070052971 country
- Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung CancerRecruitingNCT05168566Phase 23 countries
- A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid TumorsRecruitingNCT06983743Phase 13 countries
- Multimodal Artificial Intelligence for Detecting the Psychological State of Cancer PatientsEnrolling by invitationNCT077517571 country
- A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)RecruitingNCT06818643Phase 1/212 countries
- A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)RecruitingNCT05920356Phase 338 countries
- ^68Ga-grazytracer PET for In Vivo Visualization of Immune Cell Effector FunctionsRecruitingNCT07935174Not applicable1 country
- ABCSG R07 Rectal Cancer RegistryRecruitingNCT077803051 country
- Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic SyndromesRecruitingNCT07672769Phase 27 countries
- Study of a Propranolol (HEMANGIOL®) and Oral Metronomic Vinorelbine (NAVELBINE®) Combination for Children and Teenagers With Refractory/Relapsing Solid TumorsRecruitingNCT02897986Phase 11 country
- Effectiveness of the Mindful Compassion Care Program for Healthcare Professionals in Oncology and Palliative CareNot yet recruitingNCT07248111Not applicable1 country
- Sedation Methods in Percutaneous Transhepatic Biliary Drainage: Procedure Quality and RecoveryRecruitingNCT07640243Not applicable1 country
- AZD5305 hADME in Patients With Advanced Solid MalignanciesRecruitingNCT06713369Phase 11 country
- TL938 and Trastuzumab for Patients With HER2-positive Metastatic Colorectal CancerRecruitingNCT06589830Phase 21 country
- Dyadic Life Review Intervention for Older Patients With Advanced Cancer and Alzheimer's Disease and Related Dementias and Their CaregiversNot yet recruitingNCT07796347Not applicable1 country
- Weight Management in Obese Cancer Patients During Curative Active TreatmentRecruitingNCT07058207Not applicable1 country
- A Study of YL242 in Subjects With Advanced Solid TumorsRecruitingNCT07197827Phase 1/23 countries
- Using Artificial Intelligence to Guide Fluid Therapy During Major Cancer Surgery: A Randomized Controlled TrialNot yet recruitingNCT07314853Not applicable1 country
- Effects of Latin Dancing on Sleep Quality in Hispanic Cancer SurvivorsRecruitingNCT06844981Not applicable1 country
- Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney CancerRecruitingNCT000331371 country
- Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)RecruitingNCT064239501 country
- Feasibility Pilot of AYA-PARTNERRecruitingNCT07829146Not applicable1 country
- Feasibility and Acceptability of Collecting Sociodemographic Data in CCTG TrialsRecruitingNCT073904351 country
- Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)RecruitingNCT07629206Not applicable1 country
- Tumor Related EpilepsyRecruitingNCT026393251 country
- A Study of Urine Volatile Organic Compounds for Disease DetectionNot yet recruitingNCT07933042
- Evaluation for NCI Surgery Branch Clinical Research ProtocolsRecruitingNCT000018231 country
- Clinical and Genetic Studies of Li-Fraumeni SyndromeRecruitingNCT014434681 country
- Medically Tailored Meals to Improve Cancer OutcomesRecruitingNCT07924241Not applicable1 country
- Multicenter Study for External Validation of the TB-NET ScoreRecruitingNCT079035329 countries
- A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid MalignanciesRecruitingNCT07197554Phase 11 country
- Childhood Cancer Predisposition Study (CCPS)RecruitingNCT045118062 countries
- Harvesting Cells for Experimental Cancer TreatmentsEnrolling by invitationNCT000680031 country
- PharmaBag: A Sustainable Packaging System to Reduce Pharmaceutical Waste and Support a Net-Zero NHSNot yet recruitingNCT07927894